Table 4. The effect of studied compounds on the amount of intraperitoneal adipose tissue.
Control | Diet-induced obesity control | Yohimbine 2 mg/kg b.w. | Yohimbine 5 mg/kg b.w. | Guanfacine 0.5 mg/kg b.w. | Guanfacine 2 mg/kg b.w. | |
---|---|---|---|---|---|---|
Weight of intraperitoneal fat tissue [g] | 15.5 ± 2.56 | 28.5 ± 2.28** | 23.0 ± 1.49* | 14.9 ± 1.30 ## | 17.5 ± 1.14 ## | 14.2 ± 2.59 ## |
Percentage of body weight | 3.90 | 6.17 | 5.14 | 3.49 | 4.13 | 3.95 |
Weight of intraperitoneal fat tissue after 30 days treated using the test compounds in Wistar rats on diet-induced obesity. Treatment: Diet-induced obesity control group—water; Yohimbine at 2 mg/kg b.w., i.p.; Yohimbine at 5 mg/kg b.w., i.p.; Guanfacine at 0.5 mg/kg b.w., i.p.; Guanfacine at 2 mg/kg b.w., i.p.;
*Significant vs. control group, P<0.05;
**Significant vs. control group, P<0.01;
##Significant vs. diet-induced obesity control group, P<0.01.